Abstract
Abstract: Background: Iron-sulfur clusters are inorganic prosthetic groups composed of only iron and inorganic sulfur atoms. Organisms develop different pathways to sense their local environment and to respond and adapt to changes.
Objective: We focused on Fe-S-containing proteins, which control their activity in response to redox signals by changing the redox state of their cluster. Result: When reduced, these Fe-S cluster-containing sensors are all inactive. As soon as their cluster perceives a signal that induces its oxidation, they switch to an « active state ». Conclusion: This sensing mechanism efficiently helps cells to turn on survival pathways quickly and recover from stressful conditions.Keywords: Fe-S cluster, sensor, redox state, cellular adaptive response, mitoNEET, iron.
Current Chemical Biology
Title:Fe-S Proteins Acting as Redox Switch: New Key Actors of Cellular Adaptive Responses
Volume: 11 Issue: 2
Author(s): Marie-Pierre Golinelli-Cohen*Cécile Bouton*
Affiliation:
- Institut de Chimie des Substances Naturelles, UPR 2301-CNRS, 1 avenue de la Terrasse 91190 Gif-sur-Yvette, Cedex,France
- Institut de Chimie des Substances Naturelles, UPR 2301-CNRS, 1 avenue de la Terrasse 91190 Gif-sur-Yvette, Cedex,France
Keywords: Fe-S cluster, sensor, redox state, cellular adaptive response, mitoNEET, iron.
Abstract: Abstract: Background: Iron-sulfur clusters are inorganic prosthetic groups composed of only iron and inorganic sulfur atoms. Organisms develop different pathways to sense their local environment and to respond and adapt to changes.
Objective: We focused on Fe-S-containing proteins, which control their activity in response to redox signals by changing the redox state of their cluster. Result: When reduced, these Fe-S cluster-containing sensors are all inactive. As soon as their cluster perceives a signal that induces its oxidation, they switch to an « active state ». Conclusion: This sensing mechanism efficiently helps cells to turn on survival pathways quickly and recover from stressful conditions.Export Options
About this article
Cite this article as:
Golinelli-Cohen Marie-Pierre*, Bouton Cécile*, Fe-S Proteins Acting as Redox Switch: New Key Actors of Cellular Adaptive Responses, Current Chemical Biology 2017; 11 (2) . https://dx.doi.org/10.2174/2212796811666170406163809
DOI https://dx.doi.org/10.2174/2212796811666170406163809 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy
Clinical Cancer Drugs Alginate Based Nanocarriers for Drug Delivery Applications
Current Pharmaceutical Design Flavonoids and Dementia: An Update
Current Medicinal Chemistry Synthesis and Urease Inhibitory Activity of Some 5-Aminomethylene Barbituric/Thiobarbituric Acid Derivatives
Letters in Drug Design & Discovery Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology PTD/CPP Peptide-Mediated Delivery of siRNAs
Current Pharmaceutical Design Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Acetate Suppresses Lipopolysaccharide-stimulated Nitric Oxide Production in Primary Rat Microglia but not in BV-2 Microglia Cells
Current Molecular Pharmacology Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Subungueal Haemorrhages Following Docetaxel (Taxotere) Treatment
Current Drug Safety Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Current Cancer Drug Targets Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols
Anti-Cancer Agents in Medicinal Chemistry Current Status Of Short Synthetic Peptides As Vaccines
Medicinal Chemistry MicroRNA-34b Inhibits Pancreatic Cancer Metastasis Through Repressing Smad3
Current Molecular Medicine Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy ErbB Targeted Drugs and Angiogenesis
Current Vascular Pharmacology Nutritional Metabolomics: Lessons from Companion Animals
Current Metabolomics Recent Progress on Apoptotic Activity of Triazoles
Current Drug Targets